Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Teva Pharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (156)
ARTG (126)
Prescription medicine registration (23)
Australian Public Assessment Report (AusPAR) (7)
Prescription medicine decision summary (3)
Section 14, TGO91 consent (2)
Designation or determination (1)

Date

2024 (120)
2023 (16)
2022 (13)
2021 (68)
2020 (23)
2019 (11)
2018 (6)
2017 (8)
2016 (25)
2015 (9)
2012 (2)
2011 (4)
2010 (1)
2006 (3)
2002 (7)
1995 (2)

Results for "[search-keyword]"

Search

Sponsor content

318 result(s) found, displaying 311 to 318

ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack (91600)

15 November 2002

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTIQ fentanyl 400microgram (as citrate) lozenge with integral applicator blister pack.
ACTIQ fentanyl 1200microgram (as citrate) lozenge with integral applicator blister pack (91603)

15 November 2002

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTIQ fentanyl 1200microgram (as citrate) lozenge with integral applicator blister pack.
ACTIQ fentanyl 600microgram (as citrate) lozenge with integral applicator blister pack (91601)

15 November 2002

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTIQ fentanyl 600microgram (as citrate) lozenge with integral applicator blister pack.
ACTIQ fentanyl 1600microgram (as citrate) lozenge with integral applicator blister pack (91604)

15 November 2002

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTIQ fentanyl 1600microgram (as citrate) lozenge with integral applicator blister pack.
ACTIQ fentanyl 800microgram (as citrate) lozenge with integral applicator blister pack (91602)

15 November 2002

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ACTIQ fentanyl 800microgram (as citrate) lozenge with integral applicator blister pack.
ANDRODERM testosterone 24.3 mg per patch transdermal drug delivery system sachet (82398)

10 April 2002

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ANDRODERM testosterone 24.3 mg per patch transdermal drug delivery system sachet.
NEOTIGASON acitretin 10mg capsule blister pack (52455)

26 May 1995

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEOTIGASON acitretin 10mg capsule blister pack.
NEOTIGASON acitretin 25mg capsule blister pack (52456)

26 May 1995

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NEOTIGASON acitretin 25mg capsule blister pack.

Pages

First page
Previous page
…
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Current page 32

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.